Biblio

Export 330 results:
Author Title Type Year
Filters: First Letter Of Keyword is T  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
tau Proteins
Z. Li, Fan, Z., and Zhang, Q., “The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 98, no. 1, pp. 13-32, 2024.
P. Y. Ng, Zhang, C., Li, H., and Baker, D. J., “Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1751-1763, 2024.
D. Gohel, Zhang, P., Gupta, A. Kumar, Li, Y., Chiang, C. - W., Li, L., Hou, Y., Pieper, A. A., Cummings, J., and Cheng, F., “Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.”, J Alzheimers Dis, vol. 98, no. 2, pp. 643-657, 2024.
I. J. Sible and Nation, D. A., “Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1851-1860, 2024.
S. J. Czuczwar, Kocki, J., Miziak, B., Bogucki, J., Bogucka-Kocka, A., and Pluta, R., “Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years.”, J Alzheimers Dis, vol. 98, no. 1, pp. 151-161, 2024.
E. M. Sigurdsson, “Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Status of Trials and Insights from Preclinical Studies.”, J Alzheimers Dis, vol. 101, no. s1, pp. S129-S140, 2024.
I. Ferrer, “Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging.”, J Alzheimers Dis, vol. 100, no. s1, pp. S153-S164, 2024.
J. Rodrigo Do Santos, Catalão, C. Henrique R., Vulczak, A., Azzolini, A. Elisa Cale, and Alberici, L. Carla, “Voluntary wheel running decreases amyloidogenic pathway and rescues cognition and mitochondrial energy metabolism in middle-aged female 3xTg-AD mouse model of Alzheimer's disease.”, J Alzheimers Dis, vol. 102, no. 2, pp. 424-436, 2024.
R. W. B. Love, “Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-β Plaques in Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1235-1241, 2024.
R. Ali Syed, Hayat, M., Qaiser, H., Uzair, M., Al-Regaiey, K., Khallaf, R., Kaleem, I., and Bashir, S., “Aging-Related Protein Alterations in the Brain.”, J Alzheimers Dis, vol. 99, no. s1, pp. S5-S22, 2024.
Tauopathies
A. de Calignon, Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., Spires-Jones, T. L., and Hyman, B. T., “Propagation of tau pathology in a model of early Alzheimer's disease.”, Neuron, vol. 73, no. 4, pp. 685-97, 2012.
K. Iqbal, Liu, F., Gong, C. - X., and Grundke-Iqbal, I., “Tau in Alzheimer disease and related tauopathies.”, Curr Alzheimer Res, vol. 7, no. 8, pp. 656-64, 2010.
P. Jul, Volbracht, C., de Jong, I. E. M., Helboe, L., Elvang, A. Brandt, and Pedersen, J. Torleif, “Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model.”, J Alzheimers Dis, vol. 49, no. 3, pp. 783-95, 2016.
C. - C. Tan, Zhang, X. - Y., Tan, L., and Yu, J. - T., “Tauopathies: Mechanisms and Therapeutic Strategies.”, J Alzheimers Dis, vol. 61, no. 2, pp. 487-508, 2018.
X. Yin, Jiang, X., Wang, J., Qian, S., Liu, F., and Qian, W., “SIRT1 Deacetylates SC35 and Suppresses Its Function in Tau Exon 10 Inclusion.”, J Alzheimers Dis, vol. 61, no. 2, pp. 561-570, 2018.
A. Ishikawa, Tokunaga, M., Maeda, J., Minamihisamatsu, T., Shimojo, M., Takuwa, H., Ono, M., Ni, R., Hirano, S., Kuwabara, S., Ji, B., Zhang, M. - R., Aoki, I., Suhara, T., Higuchi, M., and Sahara, N., “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1037-1052, 2018.
A. Arner, Rockenstein, E., Mante, M., Florio, J., Masliah, D., Salehi, B., Adame, A., Overk, C., Masliah, E., and Rissman, R. A., “Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1201-1219, 2018.
M. Van Zeller, Dias, D., Sebastião, A. M., and Valente, C. A., “NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease.”, J Alzheimers Dis, vol. 83, no. 3, pp. 939-961, 2021.
J. M. Walker, Gonzales, M. M., Goette, W., Farrell, K., Iii, C. L. White, Crary, J. F., and Richardson, T. E., “Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1037-1049, 2023.
A. - M. C. Leiby, Scambray, K. A., Nguyen, H. L., Basith, F., Fakhraee, S., Melikyan, Z. A., Bukhari, S. A., Montine, T. J., Corrada, M. M., Kawas, C. H., and S Sajjadi, A., “Characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy Without Alzheimer's Disease and Lewy Body Dementia in the Oldest Old: A Case Series.”, J Alzheimers Dis, vol. 96, no. 1, pp. 113-124, 2023.
E. M. Sigurdsson, “Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Status of Trials and Insights from Preclinical Studies.”, J Alzheimers Dis, vol. 101, no. s1, pp. S129-S140, 2024.
Taurine
G. Spalletta, Cravello, L., Gianni, W., Piras, F., Iorio, M., Cacciari, C., Casini, A. Rosa, Chiapponi, C., Sancesario, G., Fratangeli, C., Orfei, M. Donata, Caltagirone, C., and Piras, F., “Homotaurine Effects on Hippocampal Volume Loss and Episodic Memory in Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 3, pp. 807-16, 2016.
TDP-43 Proteinopathies
A. - M. C. Leiby, Scambray, K. A., Nguyen, H. L., Basith, F., Fakhraee, S., Melikyan, Z. A., Bukhari, S. A., Montine, T. J., Corrada, M. M., Kawas, C. H., and S Sajjadi, A., “Characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy Without Alzheimer's Disease and Lewy Body Dementia in the Oldest Old: A Case Series.”, J Alzheimers Dis, vol. 96, no. 1, pp. 113-124, 2023.
Telemedicine
M. Barbera, Mangialasche, F., Jongstra, S., Guillemont, J., Ngandu, T., Beishuizen, C., Coley, N., Brayne, C., Andrieu, S., Richard, E., Soininen, H., and Kivipelto, M., “Designing an Internet-Based Multidomain Intervention for the Prevention of Cardiovascular Disease and Cognitive Impairment in Older Adults: The HATICE Trial.”, J Alzheimers Dis, vol. 62, no. 2, pp. 649-663, 2018.
B. Tousi, “Dementia Care in the Time of COVID-19 Pandemic.”, J Alzheimers Dis, vol. 76, no. 2, pp. 475-479, 2020.

Pages